Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Atenomel 50mg Tablet – PA0126/169/001
- Beclazone 200mcg CFC-Free Inhaler – PA0436/021/001
- Candist 8mg Tablet – PA0126/206/002
- Cozaar 100mg Film Coated Tablet – PA1286/004/003
- Losamel 20mg Gastro-resistant tablets – PA0126/115/001
- Lustral 50mg Film Coated Tablet – PA0822/001/004
- Mefac 500mg Film Coated Tablet – PA0074/015/002
- Nimbex 2mg/ml Solution for Injection/Infusion – PA1691/030/001
- Sildenafil 50mg film-coated tablets – PA0126/199/002
- Sildenafil 100mg film-coated tablets – PA0126/199/003
- Tipol 250mg Suppository – PA1684/002/003
- Tipol 500mg Suppository – PA1684/002/004
- Vedixal 37.5mg Tablet – PA0711/161/002
The following shortage has been resolved and supply has resumed to the Irish market:
- Fluzac 20mg Capsule – PA0711/110/001
- Ipratropium Steri-Neb 250mcg/ml Nebuliser Solution – PA1986/083/001
- Marcain Heavy Steripack 0.5% w/v Solution for Injection – PA1691/024/003
- Olanzapine 10mg Tablet – EU/1/07/427/011-014
- Quetex 25mg Film Coated Tablet – PA0711/156/001
- Rispone 6mg Film Coated Tablet – PA0711/106/005
- Rivastigmine Sandoz 6mg Capsule – EU/1/09/599/013-016
- Zomacton 10mg/ml Powder and Solvent for Solution for Injection – PA1009/008/003
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.